Suntory, Amway, Yuhan Care Drive Asia-Pacific Supplement Market with Personalised Nutrition, Gut Health, and E-commerce Expansion

Major players in the Asia-Pacific nutraceutical market are signalling strategic shifts and significant investment in key growth areas. Suntory has committed US$3.06 million to UK start-up Remedy Health, explicitly targeting the Japanese personalised nutrition market. This investment will localise Remedy Health's 3D-printed, seven-layer chewable products, branded Nourish3d, introducing a novel delivery format and competitive pressure into the Japanese market. Manufacturers should anticipate increased consumer demand for bespoke supplement solutions and a potential shift away from generic formulations, necessitating flexible manufacturing capabilities.

Meanwhile, Amway is fortifying its presence in gut microbiome research and product development from its newly established Business Innovation Hub in Singapore. This hub is a strategic platform for expanding its Nutrilite pre- and probiotic lines across South East Asia. Coupled with ongoing gut microbiome studies in South Korea, Amway's intensified R&D efforts suggest a pipeline of advanced gut health products, potentially featuring novel strains or delivery systems, expected to launch within the next 18 months. Competitors should prepare for increased marketing spend and product innovation in this high-growth category.

South Korean health supplement firm Yuhan Care, a subsidiary of Yuhan Corp, is aggressively pursuing e-commerce expansion into China and South East Asia. Specialising in women's health, the company possesses patented probiotic strains, including Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14, which claim specific benefits for the reproductive system. This market entry strategy leverages established e-commerce channels to penetrate new territories rapidly, presenting both direct competition for existing brands and potential partnership opportunities for manufacturers capable of producing or co-packing products with these specific probiotic strains.

Blackmores' new chairwoman, Wendy Stops, is actively seeking to diversify the board's expertise, aiming for new directors with stronger commercial, operational, and industry-specific backgrounds. This move underscores a strategic intent to drive 'sustainable, profitable growth' and enhance shareholder returns, indicating a refined focus on operational efficiencies and market responsiveness within the established brand. Separately, Suntory APAC highlighted the dual necessity of developing alternative packaging materials and improving recycling infrastructure to achieve its sustainability goals, signalling that packaging innovation and eco-friendly solutions will remain critical procurement considerations for ingredient suppliers and contract manufacturers alike.

What this means for Asia Pacific

Manufacturers in Asia-Pacific must prepare for heightened competition and demand for innovation. Suntory's personalised nutrition push in Japan mandates agile production for bespoke formulations, while Amway's gut health focus means R&D investment in novel pre/probiotics is critical. Yuhan Care's e-commerce entry into China and SEA, leveraging patented strains, requires existing brands to reassess their digital strategy and intellectual property. Procurement teams should explore sustainable packaging solutions and raw material suppliers capable of supporting bespoke, science-backed formulations. Compliance teams must monitor new ingredient approvals for personalised products and patented probiotic claims. Brands must differentiate through proven efficacy and streamlined supply chains to maintain market share.

For more on UK formulation and manufacturing best practice, learn more at Supplement Factory.